Skip to main content

Table 2 Schedule of events

From: All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial

Visits

Enrollment and Randomization

M1

M2

M3

M4

M5

M6

M7

M8

M9

M10

M11

M12

Identification

X

            

Screen by inclusion/exclusion criteria

X

            

Informed consent form

X

            

Initial assessment (history/physical/laboratory/imaging)

X

            

Assessment – History/physical

X

X

X

X

X

X

X

X

X

X

X

X

X

CT/MRI

X

X

X

X

X

X

X

X

X

X

X

X

X

Laboratory tests

X

X

X

X

X

X

X

X

X

X

X

X

X

Quality of life questionnaires

X

X

X

X

X

X

X

X

X

X

X

X

X

Overall survival

 

X

X

X

X

X

X

X

X

X

X

X

X

Tumor progression Assessment

 

X

X

X

X

X

X

X

X

X

X

X

X

Concomitant medication

X

X

X

X

X

X

X

X

X

X

X

X

X

AEs/SAEs

 

X

X

X

X

X

X

X

X

X

X

X

X

  1. M month, CT computed tomography, MRI magnetic resonance imaging, AE adverse event, SAE serious adverse event